301393 昊帆生物
已收盘 11-13 15:00:00
资讯
新帖
简况
昊帆生物（301393）11月6日主力资金净卖出414.36万元
证券之星 · 11-09
昊帆生物（301393）11月6日主力资金净卖出414.36万元
11月4日昊帆生物涨5.81%，农银医疗保健股票基金重仓该股
证券之星 · 11-04
11月4日昊帆生物涨5.81%，农银医疗保健股票基金重仓该股
昊帆生物（301393）11月3日主力资金净买入1184.42万元
证券之星 · 11-04
昊帆生物（301393）11月3日主力资金净买入1184.42万元
股市必读：昊帆生物新发布《2026年中期权益分派实施公告》
证券之星 · 11-04
股市必读：昊帆生物新发布《2026年中期权益分派实施公告》
11月3日昊帆生物跌5.11%，农银医疗保健股票基金重仓该股
证券之星 · 11-03
11月3日昊帆生物跌5.11%，农银医疗保健股票基金重仓该股
昊帆生物（301393）披露2026年中期权益分派实施公告，11月02日股价上涨1.23%
证券之星 · 11-02
昊帆生物（301393）披露2026年中期权益分派实施公告，11月02日股价上涨1.23%
昊帆生物（301393）10月27日主力资金净买入1041.01万元
证券之星 · 10-28
昊帆生物（301393）10月27日主力资金净买入1041.01万元
10月27日昊帆生物跌6.52%，农银医疗保健股票基金重仓该股
证券之星 · 10-27
10月27日昊帆生物跌6.52%，农银医疗保健股票基金重仓该股
破发股昊帆生物跌3.4% 2023上市超募5.1亿国联民生保荐
中金财经 · 10-26
破发股昊帆生物跌3.4% 2023上市超募5.1亿国联民生保荐
昊帆生物（301393）2026年三季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 10-25
昊帆生物（301393）2026年三季报简析：营收净利润同比双双增长，应收账款上升
昊帆生物（301393）披露2026年三季度报告，10月23日股价上涨2.97%
证券之星 · 10-23
昊帆生物（301393）披露2026年三季度报告，10月23日股价上涨2.97%
昊帆生物最新公告：前三季度净利润同比增长8.76%
证券之星 · 10-23
昊帆生物最新公告：前三季度净利润同比增长8.76%
昊帆生物（301393）10月21日主力资金净卖出193.49万元
证券之星 · 10-22
昊帆生物（301393）10月21日主力资金净卖出193.49万元
10月19日昊帆生物涨5.17%，中欧量化动力混合A基金重仓该股
证券之星 · 10-19
10月19日昊帆生物涨5.17%，中欧量化动力混合A基金重仓该股
昊帆生物（301393）10月16日主力资金净买入1092.39万元
证券之星 · 10-19
昊帆生物（301393）10月16日主力资金净买入1092.39万元
昊帆生物（301393）10月13日主力资金净卖出684.91万元
证券之星 · 10-14
昊帆生物（301393）10月13日主力资金净卖出684.91万元
昊帆生物（301393）9月23日主力资金净卖出6923.52万元
证券之星 · 09-24
昊帆生物（301393）9月23日主力资金净卖出6923.52万元
9月23日昊帆生物涨8.86%，中欧量化动力混合A基金重仓该股
证券之星 · 09-23
9月23日昊帆生物涨8.86%，中欧量化动力混合A基金重仓该股
9月18日昊帆生物发布公告，股东减持4.98万股
证券之星 · 09-18
9月18日昊帆生物发布公告，股东减持4.98万股
昊帆生物（301393）2026年中报简析：增收不增利，应收账款上升
证券之星 · 08-26
昊帆生物（301393）2026年中报简析：增收不增利，应收账款上升
加载更多
公司概况
公司名称：
苏州昊帆生物股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2023-07-12
主营业务：
苏州昊帆生物股份有限公司的主营业务是多肽合成试剂的研发、生产与销售。公司的主要产品是脂质体与脂质纳米粒药用试剂、小核酸试剂、GLP-1中间体、非天然氨基酸、离子液体、PROTAC试剂。
发行价格：
67.68
{"stockData":{"symbol":"301393","market":"SZ","secType":"STK","nameCN":"昊帆生物","latestPrice":53.59,"timestamp":1794553392000,"preClose":55.1,"halted":0,"volume":1760392,"delay":0,"changeRate":-0.0274,"floatShares":43967700,"shares":108000000,"eps":1.1422,"marketStatus":"已收盘","change":-1.51,"latestTime":"11-13 15:00:00","open":55.3,"high":55.3,"low":53.05,"amount":95275300,"amplitude":0.0408,"askPrice":53.64,"askSize":6,"bidPrice":53.59,"bidSize":18,"shortable":0,"etf":0,"ttmEps":1.1422,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":55.1,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":60.61,"lowLimit":49.59,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108000000,"isCdr":false,"pbRate":2.44,"roa":"--","peRate":46.918228,"roe":"4.5%","epsLYR":1.0695,"committee":0.893688,"marketValue":5788000000,"turnoverRate":0.04,"status":1,"floatMarketCap":2356000000},"requestUrl":"/m/hq/s/301393/","defaultTab":"news","newsList":[{"id":"2682820307","title":"昊帆生物（301393）11月6日主力资金净卖出414.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682820307","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682820307?lang=zh_cn&edition=full","pubTime":"2026-11-09 10:01","pubTimestamp":1794189683,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月6日收盘，昊帆生物报收于53.94元，下跌4.53%，换手率4.75%，成交量2.09万手，成交额1.15亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入1260.92万元，融资偿还1370.77万元，融资净偿还109.84万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900002706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680787031","title":"11月4日昊帆生物涨5.81%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680787031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680787031?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:55","pubTimestamp":1793786128,"startTime":"0","endTime":"0","summary":"证券之星消息，11月4日昊帆生物涨5.81%创60日新低，收盘报54.42元，换手率6.94%，成交量3.05万手，成交额1.61亿元。重仓昊帆生物的公募基金请见下表：根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。农银医疗保健股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400033321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680707269","title":"昊帆生物（301393）11月3日主力资金净买入1184.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680707269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680707269?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:18","pubTimestamp":1793758708,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月3日收盘，昊帆生物报收于51.43元，下跌5.11%，换手率6.51%，成交量2.86万手，成交额1.49亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入1688.99万元，融资偿还1893.42万元，融资净偿还204.42万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400014662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680776607","title":"股市必读：昊帆生物新发布《2026年中期权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680776607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680776607?lang=zh_cn&edition=full","pubTime":"2026-11-04 01:47","pubTimestamp":1793728060,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，昊帆生物报收于51.43元，下跌5.11%，换手率6.51%，成交量2.86万手，成交额1.49亿元。公司公告汇总：昊帆生物发布2026年中期权益分派实施公告，以107,181,852股为基数，每10股派1.50元现金（含税），股权登记日为2026年11月9日，除权除息日为11月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400003239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680074914","title":"11月3日昊帆生物跌5.11%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680074914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680074914?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:26","pubTimestamp":1793697987,"startTime":"0","endTime":"0","summary":"证券之星消息，11月3日昊帆生物跌5.11%创60日新低，收盘报51.43元，换手率6.51%，成交量2.86万手，成交额1.49亿元。重仓昊帆生物的公募基金请见下表：根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。农银医疗保健股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300034235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680763449","title":"昊帆生物（301393）披露2026年中期权益分派实施公告，11月02日股价上涨1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680763449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680763449?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:14","pubTimestamp":1793628851,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，昊帆生物报收于54.2元，较前一交易日上涨1.23%，最新总市值为58.54亿元。该股当日开盘53.6元，最高54.79元，最低52.52元，成交额达1.21亿元，换手率为5.13%。近日，昊帆生物发布《2026年中期权益分派实施公告》。股权登记日为2026年11月9日，除权除息日为2026年11月10日。本次权益分派实施后，将调整除权除息参考价、相关股东最低减持价格及限制性股票激励计划授予价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200036655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678438249","title":"昊帆生物（301393）10月27日主力资金净买入1041.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678438249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678438249?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:17","pubTimestamp":1793150276,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，昊帆生物报收于52.9元，下跌6.52%，换手率7.15%，成交量3.14万手，成交额1.72亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入1252.5万元，融资偿还1308.54万元，融资净偿还56.04万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800015333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678637122","title":"10月27日昊帆生物跌6.52%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678637122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678637122?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:11","pubTimestamp":1793092292,"startTime":"0","endTime":"0","summary":"证券之星消息，10月27日昊帆生物跌6.52%，收盘报52.9元，换手率7.15%，成交量3.14万手，成交额1.72亿元。重仓昊帆生物的公募基金请见下表：根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。农银医疗保健股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700032006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678169253","title":"破发股昊帆生物跌3.4% 2023上市超募5.1亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2678169253","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678169253?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:52","pubTimestamp":1793008324,"startTime":"0","endTime":"0","summary":"中国经济网北京10月26日讯 昊帆生物 今日收报56.59元，跌幅3.41%，总市值61.12亿元。 昊帆生物于2023年7月12日在深交所创业板上市，公开发行股票的数量为2,700万股，发行价格为67.68元/股，保荐人为民生证券股份有限公司，保荐代表人为邵航、刘永泓。 昊帆生物首次公开发行股票募集资金总额为182,736.00万元，扣除发行费用后，募集资金净额为165,538.87万元。 昊帆生物首次公开发行股票的发行费用为17,197.13万元，其中，保荐及承销费用14,618.88万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261026/32408118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","601456","BK1147","IPOS","01456","301393","BK1564","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678018549","title":"昊帆生物（301393）2026年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2678018549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678018549?lang=zh_cn&edition=full","pubTime":"2026-10-25 06:12","pubTimestamp":1792879957,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昊帆生物发布2026年三季报。截至本报告期末，公司营业总收入5.9亿元，同比上升35.67%，归母净利润1.08亿元，同比上升8.76%。按单季度数据看，第三季度营业总收入2.11亿元，同比上升28.06%，第三季度归母净利润3718.89万元，同比上升59.24%。本报告期昊帆生物应收账款上升，应收账款同比增幅达70.63%。财报体检工具显示：建议关注公司应收账款状况本文数据来源于昊帆生物2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102500000811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677973121","title":"昊帆生物（301393）披露2026年三季度报告，10月23日股价上涨2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677973121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677973121?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:39","pubTimestamp":1792766345,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，昊帆生物报收于58.59元，较前一交易日上涨2.97%，最新总市值为63.28亿元。该股当日开盘56.02元，最高58.88元，最低53.01元，成交额达1.9亿元，换手率为7.72%。近日，昊帆生物披露《2026年三季度报告》。报告显示，本报告期营业收入210,526,238.57元，同比增长28.06%；归属于上市公司股东的净利润37,188,880.17元，同比增长59.24%。年初至报告期末营业收入589,750,821.57元，同比增长35.67%；归属于上市公司股东的净利润107,935,157.66元，同比增长8.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300045933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940296","title":"昊帆生物最新公告：前三季度净利润同比增长8.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677940296?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:53","pubTimestamp":1792749202,"startTime":"0","endTime":"0","summary":"昊帆生物(301393.SZ)公告称，第三季度营收为2.11亿元，同比增长28.06%；净利润为3718.89万元，同比增长59.24%。前三季度营收为5.90亿元，同比增长35.67%；净利润为1.08亿元，同比增长8.76%。营收增长主要系本期销售量增加所致。注：公司Q3净利润0.372亿，Q2净利润0.373亿，据此计算，Q3净利润环比下降0.30%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300032233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677981555","title":"昊帆生物（301393）10月21日主力资金净卖出193.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677981555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677981555?lang=zh_cn&edition=full","pubTime":"2026-10-22 09:18","pubTimestamp":1792631897,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月21日收盘，昊帆生物报收于59.63元，下跌2.53%，换手率4.7%，成交量2.06万手，成交额1.25亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入1033.33万元，融资偿还688.24万元，融资净买入345.08万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200008211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509130","title":"10月19日昊帆生物涨5.17%，中欧量化动力混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509130?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:36","pubTimestamp":1792398999,"startTime":"0","endTime":"0","summary":"证券之星消息，10月19日昊帆生物涨5.17%，收盘报59.39元，换手率7.75%，成交量3.41万手，成交额1.95亿元。重仓昊帆生物的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为中欧基金的中欧量化动力混合A。中欧量化动力混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676571366","title":"昊帆生物（301393）10月16日主力资金净买入1092.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676571366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676571366?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:18","pubTimestamp":1792372701,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月16日收盘，昊帆生物报收于56.47元，下跌2.5%，换手率8.09%，成交量3.56万手，成交额2.09亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入1829.57万元，融资偿还1533.86万元，融资净买入295.71万元，连续3日净买入累计1641.14万元。昊帆生物主营业务：多肽合成试剂、通用型分子砌块及蛋白质试剂等产品的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675639999","title":"昊帆生物（301393）10月13日主力资金净卖出684.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675639999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675639999?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:16","pubTimestamp":1791940583,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，昊帆生物报收于59.68元，下跌2.1%，换手率7.88%，成交量3.46万手，成交额2.03亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入1923.53万元，融资偿还2815.6万元，融资净偿还892.06万元。昊帆生物主营业务：多肽合成试剂、通用型分子砌块及蛋白质试剂等产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430367","title":"昊帆生物（301393）9月23日主力资金净卖出6923.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430367?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:03","pubTimestamp":1790211798,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，昊帆生物报收于71.5元，上涨8.86%，换手率18.68%，成交量8.21万手，成交额5.77亿元。近5日资金流向一览见下表：昊帆生物融资融券信息显示，融资方面，当日融资买入3450.87万元，融资偿还4494.72万元，融资净偿还1043.85万元。昊帆生物主营业务：多肽合成试剂、通用型分子砌块及蛋白质试剂等产品的研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400008820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669410947","title":"9月23日昊帆生物涨8.86%，中欧量化动力混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669410947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669410947?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:41","pubTimestamp":1790152881,"startTime":"0","endTime":"0","summary":"证券之星消息，9月23日昊帆生物涨8.86%，收盘报71.5元，换手率18.68%，成交量8.21万手，成交额5.77亿元。重仓昊帆生物的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为中欧基金的中欧量化动力混合A。中欧量化动力混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668942436","title":"9月18日昊帆生物发布公告，股东减持4.98万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668942436","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668942436?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:01","pubTimestamp":1789725698,"startTime":"0","endTime":"0","summary":"证券之星消息，9月18日昊帆生物发布公告《昊帆生物:关于员工战略配售资管计划减持计划期限届满暨实施情况的公告》，其股东民生证券-中信银行-民生证券昊帆生物战略配售1号集合资产管理计划于2026年6月18日至2026年9月17日间合计减持4.98万股，占公司目前总股本的0.0461%，变动期间该股股价上涨14.05%，截止9月17日收盘报58.94元。股东增减持详情见下表：根据昊帆生物2026年中报公布的十大股东详情如下：本文数据来源于昊帆生物公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800028413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301393","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750010","title":"昊帆生物（301393）2026年中报简析：增收不增利，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750010","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662750010?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:47","pubTimestamp":1787698054,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昊帆生物发布2026年中报。截至本报告期末，公司营业总收入3.79亿元，同比上升40.3%，归母净利润7074.63万元，同比下降6.77%。本报告期昊帆生物应收账款上升，应收账款同比增幅达88.42%。营业收入变动幅度为40.3%,原因:公司自2025年7月起将杭州福斯特纳入合并范围，因此本报告期合并范围大于上年同期。财报体检工具显示：建议关注公司应收账款状况本文数据来源于昊帆生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600011941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","301393"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794684086149,"stockEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":-0.0782},{"period":"3month","weight":-0.212},{"period":"6month","weight":-0.0723},{"period":"1year","weight":-0.0358},{"period":"ytd","weight":0.0646}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州昊帆生物股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"11560人(较上一季度增加27.73%)","perCapita":"3803股","listingDate":"2023-07-12","address":"江苏省苏州市虎丘区高新区长亭路1号","registeredCapital":"10800万元","survey":" 苏州昊帆生物股份有限公司的主营业务是多肽合成试剂的研发、生产与销售。公司的主要产品是脂质体与脂质纳米粒药用试剂、小核酸试剂、GLP-1中间体、非天然氨基酸、离子液体、PROTAC试剂。","listedPrice":67.68},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊帆生物(301393)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊帆生物(301393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊帆生物,301393,昊帆生物股票,昊帆生物股票老虎,昊帆生物股票老虎国际,昊帆生物行情,昊帆生物股票行情,昊帆生物股价,昊帆生物股市,昊帆生物股票价格,昊帆生物股票交易,昊帆生物股票购买,昊帆生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊帆生物(301393)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊帆生物(301393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}